Please provide your email address to receive an email when new articles are posted on . Patients with cardiac amyloidosis who were carefully selected for heart transplantation had similar outcomes ...
Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...
A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy, according to a multicenter study ...
BOYNTON BEACH, Fla. — In the last five years, Dennis Ennis has lost five of his 12 siblings to congestive heart failure, but he didn’t consider his own risk, even when he started having shortness of ...
A report from the World Heart Federation provides an overview of transthyretin amyloid cardiomyopathy (ATTR-CM), including tools for diagnosis and patient management, highlighting the importance of ...
DANVILLE, Pa. — Cardiac amyloidosis is a heart condition caused by protein buildup between the muscle cells of the heart. "Once it gets into the heart, it thickens the heart. It's not the muscle that ...
MUNICH — Treatment with tafamidis (Vyndaqel, Pfizer) was associated with a reduction in all-cause mortality, as well as cardiovascular hospitalizations, and functional decline vs placebo in a new ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tenosynovial tissue sampling at the time of carpal tunnel ...
Heart transplant is a viable treatment option for adults at an advanced stage of cardiac amyloidosis, as overall survival after transplantation has continued to improve over 3 decades, data from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback